United States · Bill · HR
H.R. 1300 (114th)
First Responder Anthrax Preparedness Act
Introduced
4 March 2015
Last action
—
Status
Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Sponsors
—
Subjects
Discovery layer
Source updated
6 December 2025
Summary
First Responder Anthrax Preparedness Act Amends the Homeland Security Act of 2002 to direct the Department of Homeland Security (DHS), for the purpose of domestic preparedness for and collective response to terrorism, to: (1) make available surplus vaccines and antimicrobials, and vaccines and antimicrobials with short shelf lives, from the strategic national stockpile for administration to emergency response providers who voluntarily consent to such administration; (2) establish any necessary logistical and tracking systems to facilitate making such vaccines and antimicrobials available; and (3) distribute disclosures regarding associated risks to end users. Requires DHS to: (1) support homeland security-focused risk analysis and assessments of the threats posed by anthrax from an act of terror; (2) leverage homeland security intelligence capabilities and structures to enhance prevention, protection, response, and recovery efforts with respect to an anthrax terror attack; and (3) share information and provide tailored analytical support on threats posed by anthrax to state, local, and tribal authorities, as well as other national biosecurity and biodefense stakeholders. Directs DHS to carry out a pilot program, which lasts at least 18 months, to administer such vaccines and antimicrobials to emergency response providers. Requires DHS: (1) prior to implementing such program, to establish a communication platform and education and training modules for the program , to conduct economic analysis of the program, and to create a logistical platform for the anthrax vaccine request process; and (2) to select providers based in at least two states to participate in the program. Requires DHS to provide to each participating provider disclosures and educational materials regarding the risks of any vaccine or antimicrobial administered and of exposure to anthrax.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
11 official files
Referred in Senate (text)
Referred in Senate (text)
Referred in Senate · EN · 30 July 2015
Referred in Senate (PDF)
Referred in Senate · EN · 30 July 2015
Engrossed in House (text)
Engrossed in House · EN · 29 July 2015
Engrossed in House (PDF)
Engrossed in House · EN · 29 July 2015
Passed House amended
summary · EN · 29 July 2015
Reported in House (text)
Reported in House · EN · 22 July 2015
Reported in House (PDF)
Reported in House · EN · 22 July 2015
Reported to House amended, Part I
summary · EN · 22 July 2015
Introduced in House (text)
Introduced in House · EN · 4 March 2015
Introduced in House (PDF)
Introduced in House · EN · 4 March 2015
Introduced in House
summary · EN · 4 March 2015
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/1300
- Open data entity: https://api.congress.gov/v3/bill/114/hr/1300